Scottish Diabetes Survey 2009 Scottish Diabetes Survey Monitoring Group

2

Foreword The Scottish Diabetes Survey is now in its ninth year. This 2009 Survey, as with previous versions, continues to demonstrate an increase in the prevalence of diabetes and an increase in recording key data that reflects the quality of diabetes care across the whole of Scotland. This provides useful information for the Scottish Diabetes Action Plan review and should aid and influence NHS Boards in Scotland in service planning, audit and with quality improvement. It also offers great potential for epidemiological research. The survey has some major strengths; • It provides information on the whole population • The data items collected are nationally agreed and evidence based • The information is provided at NHS Board level, each responsible for the healthcare of their region. • The system used to collect the data is integrated into the provision of care, and is available at all levels – from data for one individual, through the general practice, hospital unit, GP group, NHS Board and nationally. The information collected also presents NHS Scotland a number of challenges • The increasing prevalence of diabetes presents an organisational and resource pressure • There are still many patients who do not appear to have key parameters measured or recorded. In two NHS Boards an automatic link between SCI-Store and SCI-DC has improved data capture and this will be implemented across all Boards this year. • In this report we have presented data from people with Type 1 and Type 2 diabetes separately and found that 38 % of those with Type 1 diabetes have poor glycaemic control. • There are data collection issues for those people with diabetes who receive specialist care at a clinic which does not link directly to the SCI-DC system. This will include some paediatric clinics and will rely on primary care staff entering the data from clinic letters. • 20 % of people with diabetes do not appear to have an up-to-date eye screen, and this is worse (26 %) in those with Type 1 diabetes who are at greater risk of proliferative retinopathy. • The use of the foot screening risk calculation needs further emphasis as it is not widely used. In this survey we also attempted to ascertain what proportion of people with diabetes was achieving ideal targets for glycaemia, blood pressure and cholesterol. The glycaemic target was probably set unrealistically low making this calculation difficult to interpret. The launch of the 2010 SIGN guideline for diabetes and the Diabetes Action Plan review presents a further opportunity to build on the work of the survey to encourage further improvements in diabetes care in Scotland.

John A McKnight Chairman Scottish Diabetes Survey Monitoring Group 3

page

Contents

Foreword .................................................................................................................................. 3 Executive Summary ................................................................................................................. 5 Prevalence................................................................................................................................ 6 Gender ...................................................................................................................................... 9 Duration of Diabetes ................................................................................................................ 9 Age...........................................................................................................................................10 Type of diabetes......................................................................................................................11 Ethnicity...................................................................................................................................13 Body Mass Index................................................................................